Search Results - "Boluda, J.C."

An active methodology for teaching electronic systems design by Boluda, J.C., Peiro, M.A., Torres, M.A.L., Girones, R., Palero, R.J.C.

“…The study of programmable logic devices (PLDs) is one of the more accessible branches of microelectronics, given the conceptual simplicity and relative ease…”
Get full text

Study of toxicity of the conventional treatments in myeloproliferative neoplasms, based on the functional status of the RUNX1/CBF-BETA/P300/HIPK2 complex by Lozano Asencio, C., Cervera Vidal, R., Climent Bataller, J., Hernández Boluda, J.C.

Get full text

Successful treatment of hepatitis C virus infection with sofosbuvir and simeprevir in the early phase of an allogeneic stem cell transplant by Piñana, J.L., Serra, M.Á., Hernández‐Boluda, J.C., Navarro, D., Calabuig, M., Solano, C.

“…Currently, a lack of consensus exists on how to manage a hepatitis C virus (HCV) infection after allogeneic hematopoietic stem cell transplantation…”
Get full text

PF670 MOLECULAR CLASSIFICATION OF PATIENTS WITH POLYCYTHEMIA VERA OR ESSENTIAL THROMBOCYTHEMIA WHO DEVELOP RESISTANCE OR INTOLERANCE TO HYDROXYUREA by Díaz, Á., Larrán, A. Álvarez, Casterá, E. Mora, Taboada, E. Such, Figueras, A. Angona, Gómez‐Casares, M.T., Carreño‐Tarragona, G., Gutiérrez, V. García, Hernández, M.C. García, Bellosillo, B., Avetisyan, G., Cervera, J.V., Boluda, J.C. Hernández

“…Background: A recent study (Grinfeld et al, NEJM 2018) has proposed a genomic classification of myeloproliferative neoplasms (MPN) that predicts patients’…”
Get full text

PS1186 CURRENT DOSE RECOMMENDATIONS FOR PONATINIB IN CHRONIC MYELOID LEUKEMIA PATIENTS CAN DIMINISH ADVERSE EVENTS WHILE MAINTAINING EFFICACY by Garcia‐Gutierrez, V., Hernandez‐Boluda, J.C., Moiraghi, B., Sacha, E.S. Tomasz, Pavlovsky, C., Grzybowska‐Izydorczyk, O., Correa, J., Lopez, R. Perez, Góra‐Tybor, E.P. Joanna, Garcia, A. Novo, Prendes, S. Osorio, Vallansot, R., Payer, A. Ramirez, Wasilewska, E., Villaespesa, M. Piris, Genovard, C. Boque, Encinas, M. Perez, Velasco, A. Jimenez, Sanchez‐Guijo, F., Collada, M.A. Romo, Casares, M.T. Gomez, Pascual, G. Orti, Duran, M.S., Portero, A., Mata, M.I., Noya, M.S., Caballero, G., Garcia, N., Castro, D. Robles, Ramirez, M.J., Magan, A. Senin, Lakhwani, S., Dominguez, J.M. Alonso, Montero, M.I., Chulvi, M.J. Lis, Ciepłuch, H., Steegman, J.L.

“…Background: Ponatinib has been established as an optimal salvage treatment option in chronic myeloid leukemia (CML) patients. Serious adverse events, mainly…”
Get full text

Reconstitution of CMV pp65 and IE-1-specific IFN-[gamma] [CD8.sup.+] and [CD4.sup.+] T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT by Tormo, N, Solano, C, Benet, I, Nieto, J, de la Camara, R, Lopez, J, Garcia-Noblejas, A, Munoz-Cobo, B, Costa, E, Clari, M.A, Hernandez-Boluda, J.C, Remigia, M.J, Navarro, D

“…Threshold levels of CMV-specific T-cell populations presumably affording protection from active CMV infection in allo-SCT recipients have been proposed, but…”
Get full text

Feasibility of tyrosine kinase inhibitor (TKI) treatment in older patients with Ph + chronic myeloid leukemia (CML) by Boque, C

Get full text

Feasibility of tyrosine kinase inhibitor (TKI) treatment in older patients with Ph + chronic myeloid leukemia (CML): A Spanish group of CML (GELMC) retrospective study by Boque, C., Boqué, C., Vélez, P., Encuentra, M., Gómez, M.T., Sánchez-Guijo, F., Rámila, R., De las Heras, N., Pérez, M., Xicoy, B., Ramírez, A., Boluda, J.C., Martínez, J., Hernández, J.A., Fernández, C., Ferrer, F., Burgaleta, C., Gonzál

Get full text

Surveillance for adenovirus DNAemia early after transplantation in adult recipients of unrelated-donor allogeneic stem cell transplants in the absence of clinically suspected infection by Muñoz-Cobo, B, Solano, C, Nieto, J, de la Cámara, R, Remigia, M J, Garcia-Noblejas, A, López, J, Benet, I, Hernández-Boluda, J C, Costa, E, Bravo, D, Navarro, D

Get full text

Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFN[gamma] [CD8.sup.+] and [CD4.sup.+] T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients by Tormo, N, Solano, C, Benet, I, Clari, M.A, Nieto, J, de la Camara, R, Lopez, J, Lopez-Aldeguer, N, Hernandez-Boluda, J.C, Remigia, M.J, Garcia-Noblejas, A, Gimeno, C, Navarro, D

“…Rising levels of cytomegalovirus (CMV) DNAemia and/or pp65 antigenemia have been observed during pre-emptive ganciclovir therapy in patients undergoing…”
Get full text

Impact of In Vivo T-Cell Depletion on Outcome Following Reduced Intensity Transplantation for Hodgkin Lymphoma: Comparison between 2 Prospective Studies by Peggs, K.S., Sureda, A., Hunter, A., Caballero, M.D., Cavet, J., Urbano-Ispizua, A., Parker, A., Ribera, J.M., Mahendra, P., Canales, M.A., Milligan, D., Hernandez-Boluda, J.C., Morris, E.C., Alvarez, I., Goldstone, A.H., Linch, D.C., Sierra, J., Mackinnon, S.

“…Despite impressive primary response rates relatively few patients with multiply relapsed or refractory Hodgkin lymphoma (HL) are ultimately cured with…”
Get full text

Idiopathic Myelofibrosis Associated with Primary Biliary Cirrhosis by Hernández-Boluda, J.C., Jiménez, M., RosiÑol, L., Cervantes, F.

“…A patient with primary biliary cirrhosis (PBC) who developed idiopathic myelofibrosis (IM) is reported. The initial diagnosis of PBC was established by liver…”
Get full text

Successful treatment of hepatitis C virus infection with sofosbuvir and simeprevir in the early phase of an allogeneic stem cell transplant by Piñana, J.L., Serra, M.Á., Hernández-Boluda, J.C., Navarro, D., Calabuig, M., Solano, C.

Get full text

CSDL & GLIDER: CAD Tools for Hardware Implementation of Cellular Automata by Jodar, N.F., Boluda, J.C., Girones, R.G., Bosch, V.H.

“…Cellular Automata (CA) are discrete dynamical systems. Physically, a CA consists of consist of a lattice of discrete identical sites called cells, each one…”
Get full text

CSDL & GLIDER: Tools for implementing cellular structures into FPGAs by Jodar, N.F., Boluda, J.C., Girones, R.G., Bosch, V.H.

“…Cellular Automata (CA) consist of a lattice of discrete identical sites called cells, each one taking a value from a finite set. The values of the cells evolve…”
Get full text